Putatively Silent Chemokine Receptor D6 CC Chemokines by the Promiscuous Cutting Edge: Scavenging of Inflammatory
暂无分享,去创建一个
M. Gobbi | A. Mantovani | S. Sozzani | M. Sironi | M. Locati | A. Vecchi | K. Otero | P. Signorelli | M. Massardi
[1] J. Sedgwick,et al. Tumor Necrosis Factor–dependent Segmental Control of MIG Expression by High Endothelial Venules in Inflamed Lymph Nodes Regulates Monocyte Recruitment , 2001, The Journal of experimental medicine.
[2] Steffen Jung,et al. Inflammatory Chemokine Transport and Presentation in HEV , 2001, The Journal of experimental medicine.
[3] T. Schwartz,et al. The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. , 2001, Molecular biology of the cell.
[4] M Locati,et al. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. , 2001, Trends in immunology.
[5] D. Kerjaschki,et al. The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. , 2001, The American journal of pathology.
[6] M. Thelen,et al. Dancing to the tune of chemokines , 2001, Nature Immunology.
[7] Rob Leurs,et al. Constitutive Signaling of the Human Cytomegalovirus-encoded Chemokine Receptor US28* , 2001, The Journal of Biological Chemistry.
[8] P. Allavena,et al. Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys , 2000, Nature Immunology.
[9] K. Matsushima,et al. International union of pharmacology. XXII. Nomenclature for chemokine receptors. , 2000, Pharmacological reviews.
[10] A. Zlotnik,et al. Chemokines: a new classification system and their role in immunity. , 2000, Immunity.
[11] K. Alitalo,et al. Lymphatic endothelial tumors induced by intraperitoneal injection of incomplete Freund's adjuvant. , 1999, Experimental cell research.
[12] C. Vita,et al. Chemokine Sequestration by Viral Chemoreceptors as a Novel Viral Escape Strategy: Withdrawal of Chemokines from the Environment of Cytomegalovirus-infected Cells , 1998, The Journal of experimental medicine.
[13] R. Nibbs,et al. Cloning and Characterization of a Novel Promiscuous Human β-Chemokine Receptor D6* , 1997, The Journal of Biological Chemistry.
[14] M. Auer,et al. Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells , 1997, Cell.
[15] D. Steiner,et al. Cloning, expression, and chromosomal mapping of a novel human CC-chemokine receptor (CCR10) that displays high-affinity binding for MCP-1 and MCP-3. , 1997, DNA and cell biology.
[16] Zhaohua Lu,et al. The Duffy antigen receptor for chemokines: structural analysis and expression in the brain , 1996, Journal of leukocyte biology.
[17] A. Mantovani,et al. Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4. , 1993, Science.
[18] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.